Verrica Pharmaceuticals sell Lokrim
Start price
20.08.24
/
20%
€2.50
Target price
20.08.25
-
Performance (%)
-76.66%
End price
21.08.25
-
Summary
This prediction is currently being closed. Massive losses of -76.66% have been the result for the SELL prediction by Lokrim. Lokrim has 20% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Verrica Pharmaceuticals | - | - | - |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
According to Lokrim what are the pros and cons of Verrica Pharmaceuticals for the foreseeable future?
Pros
Cons
Revenue decline/stagnation expected
Risky Investment
Comments by Lokrim for this prediction
In the thread Verrica Pharmaceuticals diskutieren
Sell Verrica Pharmaceuticals
In the thread Trading Verrica Pharmaceuticals
Die von Lokrim gewählte maximale Laufzeit wurde überschritten